Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation

By Panoff J.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 899-906

Springer Publishing Company

Access to resources Recommend Favorite

Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among ‘high risk' pre- and postmenopausal breast cancer patients

By Rutqvist Lars   Johansson Hemming  

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 517-527

Informa Healthcare

Access to resources Recommend Favorite

Tamoxifen in High-risk Premenopausal Women with Primary Breast Cancer Receiving Adjuvant Chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B Trial

By Andersson M.   Kamby C.   Jensen M.-B.   Mouridsen H.   Ejlertsen B.   Dombernowsky P.   Rose C.   Cold S.   Overgaard M.   Andersen J.   Kjaer M.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1659-1666

Elsevier

Access to resources Recommend Favorite

Re Panoff et al., Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation

By Graham Peter  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 353-355

Springer Publishing Company

Access to resources Recommend Favorite

Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: Updated results of a prospective randomized trial

By Wallace III H James  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 121-122

Informa Healthcare

Access to resources Recommend Favorite